Protagonist Therapeutics(DE:PGF)
€75.000.00 (0.00%)
DE:PGF
Protagonist Therapeutics ownership
€75.00
At close:0.00 (0.00%)
Protagonist Therapeutics (PGF) Ownership - Who Owns Protagonist Therapeutics?
1 Followers
Protagonist Therapeutics (PGF) Ownership Overview
- 1.17% Insiders
- 29.63% Mutual Funds
- 6.51% Other Institutional Investors
- 28.29% ETFs
- 34.40% Public Companies and Individual Investors
The ownership structure of Protagonist Therapeutics (DE:PGF) stock is a mix of institutional, retail, and individual investors. Approximately 64.43% of the company’s stock is owned by Institutional Investors, 1.17% is owned by Insiders, and 34.40% is owned by Public Companies and Individual Investors.
The ownership structure of Protagonist Therapeutics (DE:PGF) stock is a mix of institutional, retail, and individual investors. Approximately 64.43% of the company’s stock is owned by Institutional Investors, 1.17% is owned by Insiders, and 34.40% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Sep 09, 2026 | Dinesh V Ph D Patel | $18,240,568 | |
| Aug 11, 2026 | Dinesh V Ph D Patel | $14,890,799 | |
| Jun 24, 2026 | William Waddill | $1,061,460 | |
| Jun 10, 2026 | William Waddill | $969,120 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Hussman Strategic Advisors Inc | €1,100,484 | |
| Dec 31, 2025 | Fisher Asset Management Llc | €5,687,056 | |
| Dec 31, 2025 | Soros Fund Mangment Llc | €8,734,000 | |
| Dec 31, 2025 | Driehaus Capital Management Llc | €96,001,507 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 10,307,837 | Institution | 15.79% | 857,859,426 |
| Ishares | 7,700,694 | Institution | 11.80% | 640,882,557 |
| Andrew J.M. Spokes | 6,348,906 | Institution | 9.73% | 528,381,353 |
| Vanguard | 6,053,007 | Institution | 9.27% | 503,755,455 |
| Vanguard Index Funds | 5,063,728 | Institution | 7.76% | 421,423,699 |
| Spdr | 2,245,916 | Institution | 3.44% | 186,914,113 |
| Michael Rockefeller | 1,414,173 | Institution | 2.17% | 117,693,134 |
| Vanguard Specialized Funds | 1,243,618 | Institution | 1.91% | 103,498,864 |
| Joseph Edelman | 981,879 | Institution | 1.50% | 81,715,898 |
| Janus Investment Fund | 971,779 | Institution | 1.49% | 80,875,335 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 5,063,728 | Institution | 7.76% | 421,423,699 |
| Vanguard Specialized Funds | 1,243,618 | Institution | 1.91% | 103,498,864 |
| Janus Investment Fund | 971,779 | Institution | 1.49% | 80,875,335 |
| Fidelity Salem Street Trust | 918,952 | Institution | 1.41% | 76,478,861 |
| Vanguard Explorer Fund | 881,156 | Institution | 1.35% | 73,333,327 |
| T. Rowe Price Health Sciences Fund, Inc. | 828,559 | Institution | 1.27% | 68,955,994 |
| Fidelity Select Portfolios | 607,713 | Institution | 0.93% | 50,576,307 |
| Fidelity Concord Street Trust | 600,072 | Institution | 0.92% | 49,940,392 |
| American Century Mutual Funds, Inc. | 455,742 | Institution | 0.70% | 37,928,672 |
| Manager Directed Portfolios | 437,518 | Institution | 0.67% | 36,411,998 |
FAQ
Who Owns Protagonist Therapeutics (DE:PGF)?
According to the latest TipRanks data, approximately 64.43% of the company's stock is held by institutional investors, 1.17% is held by insiders, and 34.40% is held by public companies and individual investors.
What percentage of Protagonist Therapeutics (DE:PGF) stock is held by institutional investors?
According to the latest TipRanks data, approximately 64.43% of Protagonist Therapeutics (DE:PGF) stock is held by institutional investors: 29.63% by mutual funds, 28.29% by ETFs and 6.51% by other institutional investors.
What percentage of Protagonist Therapeutics (DE:PGF) stock is held by retail investors?
According to the latest TipRanks data, approximately 34.40% of Protagonist Therapeutics (DE:PGF) stock is held by public companies and individual investors.
Who owns the most shares of Protagonist Therapeutics (DE:PGF)?
BlackRock, Inc. owns the most shares of Protagonist Therapeutics (DE:PGF).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
